MiniMed Group, Inc. Common Stock (MMED) - Net Assets
Based on the latest financial reports, MiniMed Group, Inc. Common Stock (MMED) has net assets worth $3.61 Billion USD as of April 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.63 Billion) and total liabilities ($1.02 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore net asset growth rate of MiniMed Group, Inc. Common Stock to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $3.61 Billion |
| % of Total Assets | 77.99% |
| Annual Growth Rate | 2.34% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 5.9 |
MiniMed Group, Inc. Common Stock - Net Assets Trend (2024–2026)
This chart illustrates how MiniMed Group, Inc. Common Stock's net assets have evolved over time, based on quarterly financial data. See MiniMed Group, Inc. Common Stock balance sheet independence to measure how much of total assets are equity-financed.
Annual Net Assets for MiniMed Group, Inc. Common Stock (2024–2026)
The table below shows the annual net assets of MiniMed Group, Inc. Common Stock from 2024 to 2026. For live market cap and overall valuation, see market value of MiniMed Group, Inc. Common Stock.
| Year | Net Assets | Change |
|---|---|---|
| 2026-04-30 | $3.61 Billion | +8.41% |
| 2025-04-30 | $3.33 Billion | -3.39% |
| 2024-04-30 | $3.45 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to MiniMed Group, Inc. Common Stock's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 11600000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (April 2026)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $3.00 Million | 0.08% |
| Other Comprehensive Income | $-12.00 Million | -0.33% |
| Other Components | $3.74 Billion | 103.46% |
| Total Equity | $3.61 Billion | 100.00% |
MiniMed Group, Inc. Common Stock Competitors by Market Cap
The table below lists competitors of MiniMed Group, Inc. Common Stock ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
MDU Resources Group Inc
NYSE:MDU
|
$4.27 Billion |
|
FLSmidth & Co.
CO:FLS
|
$4.27 Billion |
|
Nanjing Iron & Steel Co Ltd
SHG:600282
|
$4.27 Billion |
|
PT Alamtri Resources Indonesia Tbk
JK:ADRO
|
$4.27 Billion |
|
Klabin S.A.
SA:KLBN11
|
$4.26 Billion |
|
Mattel Inc
NASDAQ:MAT
|
$4.26 Billion |
|
Hanwha Solutions
KO:009830
|
$4.25 Billion |
|
Zhejiang Dingli Mach Co Ltd
SHG:603338
|
$4.25 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in MiniMed Group, Inc. Common Stock's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2025 to 2026, total equity changed from 3,331,000,000 to 3,611,000,000, a change of 280,000,000 (8.4%).
- Net loss of 331,000,000 reduced equity.
- New share issuances of 538,000,000 increased equity.
- Other comprehensive income decreased equity by 15,000,000.
- Other factors increased equity by 88,000,000.
Equity Change Factors (2025 to 2026)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-331.00 Million | -9.17% |
| Share Issuances | $538.00 Million | +14.9% |
| Other Comprehensive Income | $-15.00 Million | -0.42% |
| Other Changes | $88.00 Million | +2.44% |
| Total Change | $- | 8.41% |
Book Value vs Market Value Analysis
This analysis compares MiniMed Group, Inc. Common Stock's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.39x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.59x to 1.39x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2024-04-30 | $12.28 | $19.50 | x |
| 2025-04-30 | $11.86 | $19.50 | x |
| 2026-04-30 | $14.07 | $19.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently MiniMed Group, Inc. Common Stock utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -9.17%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -10.67%
- • Asset Turnover: 0.67x
- • Equity Multiplier: 1.28x
- Recent ROE (-9.17%) is below the historical average (-6.64%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2024 | -3.25% | -4.54% | 0.60x | 1.19x | $-456.80 Million |
| 2025 | -7.51% | -9.21% | 0.65x | 1.26x | $-583.10 Million |
| 2026 | -9.17% | -10.67% | 0.67x | 1.28x | $-692.10 Million |
Industry Comparison
This section compares MiniMed Group, Inc. Common Stock's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,292,880,516
- Average return on equity (ROE) among peers: -28.00%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| MiniMed Group, Inc. Common Stock (MMED) | $3.61 Billion | -3.25% | 0.28x | $4.26 Billion |
| Akoya Biosciences Inc (AKYA) | $58.58 Million | -120.59% | 2.00x | $64.44 Million |
| Align Technology Inc (ALGN) | $-84.67 Million | 0.00% | 0.00x | $12.09 Billion |
| AngioDynamics Inc (ANGO) | $123.44 Million | 5.56% | 0.11x | $447.90 Million |
| AptarGroup Inc (ATR) | $880.43 Million | 10.60% | 0.56x | $7.66 Billion |
| AtriCure Inc (ATRC) | $29.12 Million | -34.92% | 0.49x | $1.38 Billion |
| Avinger Inc (AVGR) | $-6.20 Million | 0.00% | 0.00x | $1.52 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $62.68 Million | -121.71% | 0.29x | $872.19 Million |
| Avantor Inc (AVTR) | $5.25 Billion | 6.11% | 1.47x | $5.44 Billion |
| Azenta Inc (AZTA) | $717.83 Million | 16.24% | 0.53x | $1.17 Billion |
| Baxter International Inc (BAX) | $5.89 Billion | -41.27% | 3.80x | $9.94 Billion |
About MiniMed Group, Inc. Common Stock
MiniMed Group, Inc. operates as a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company offers technologies including insulin delivery devices, including insulin pumps and pens, continuous glucose monitors, other consumables, supplies, and related software and services. It serves people with diabetes who require insulin t… Read more